Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

During the Trading Day
131.25 -0.63 / -0.48%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
131.65 +0.40 / +0.30%
 
Volume: 311.8K

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Celgene have a median target of 153.50, with a high estimate of 191.00 and a low estimate of 82.00. The median estimate represents a +16.95% increase from the last price of 131.25.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Celgene. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.21
Sales
$2.4B
Reporting Date
Oct 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.47%
 
 
 
 
 
 
Growthannually 29.24%
 
 
 
 
 
 

Sales

Growthquarterly 5.18%
 
 
 
 
 
 
Growthannually 20.85%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.